These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 31202904)
1. Gene promoter methylation and cancer: An umbrella review. Bouras E; Karakioulaki M; Bougioukas KI; Aivaliotis M; Tzimagiorgis G; Chourdakis M Gene; 2019 Aug; 710():333-340. PubMed ID: 31202904 [TBL] [Abstract][Full Text] [Related]
2. MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta-analysis. Chen B; Ying X; Bao L Thorac Cancer; 2021 Dec; 12(23):3194-3200. PubMed ID: 34651448 [TBL] [Abstract][Full Text] [Related]
3. [A meta-analysis of Association between MGMT gene promoter methylation and non-small cell lung cancer]. Fang N; Gu J; Wei H; You J; Zhou Q Zhongguo Fei Ai Za Zhi; 2014 Aug; 17(8):601-5. PubMed ID: 25130966 [TBL] [Abstract][Full Text] [Related]
4. The Association Between MGMT Promoter Methylation and Patients with Gastric Cancer: A Meta-Analysis. Yuan X; Xu J; Fang W; Zhao Z; Wang F; Tong Z Genet Test Mol Biomarkers; 2017 Apr; 21(4):213-221. PubMed ID: 28384044 [TBL] [Abstract][Full Text] [Related]
5. Promoter methylation as biomarkers for diagnosis of melanoma: A systematic review and meta-analysis. Guo Y; Long J; Lei S J Cell Physiol; 2019 May; 234(5):7356-7367. PubMed ID: 30370527 [TBL] [Abstract][Full Text] [Related]
6. DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions. Sun Y; Li S; Shen K; Ye S; Cao D; Yang J Int J Clin Exp Pathol; 2015; 8(11):14939-45. PubMed ID: 26823825 [TBL] [Abstract][Full Text] [Related]
7. Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer. Walter RFH; Rozynek P; Casjens S; Werner R; Mairinger FD; Speel EJM; Zur Hausen A; Meier S; Wohlschlaeger J; Theegarten D; Behrens T; Schmid KW; Brüning T; Johnen G PLoS One; 2018; 13(5):e0195716. PubMed ID: 29851970 [TBL] [Abstract][Full Text] [Related]
8. Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma. Kontic M; Stojsic J; Jovanovic D; Bunjevacki V; Ognjanovic S; Kuriger J; Puumala S; Nelson HH Clin Lung Cancer; 2012 Jul; 13(4):297-303. PubMed ID: 22169480 [TBL] [Abstract][Full Text] [Related]
9. A systematic review and meta-analysis: Association between MGMT hypermethylation and the clinicopathological characteristics of non-small-cell lung carcinoma. Chen L; Wang Y; Liu F; Xu L; Peng F; Zhao N; Fu B; Zhu Z; Shi Y; Liu J; Wu R; Wang C; Yao S; Li Y Sci Rep; 2018 Jan; 8(1):1439. PubMed ID: 29362385 [TBL] [Abstract][Full Text] [Related]
10. Determination of O⁶-methylguanine DNA methyltransferase promoter methylation in non-small cell lung cancer. Ekim M; Caner V; Büyükpınarbaşılı N; Tepeli E; Elmas L; Bağcı G Genet Test Mol Biomarkers; 2011 May; 15(5):357-60. PubMed ID: 21288129 [TBL] [Abstract][Full Text] [Related]
11. Association of MGMT promoter methylation with tumorigenesis features in patients with ovarian cancer: A systematic meta-analysis. Qiao B; Zhang Z; Li Y Mol Genet Genomic Med; 2018 Jan; 6(1):69-76. PubMed ID: 29195029 [TBL] [Abstract][Full Text] [Related]
12. Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis. Huang J; Luo JY; Tan HZ PLoS One; 2019; 14(10):e0222772. PubMed ID: 31574102 [TBL] [Abstract][Full Text] [Related]
13. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Buckingham L; Penfield Faber L; Kim A; Liptay M; Barger C; Basu S; Fidler M; Walters K; Bonomi P; Coon J Int J Cancer; 2010 Apr; 126(7):1630-9. PubMed ID: 19795445 [TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of MGMT gene may contribute to the pathogenesis of gastric cancer: A PRISMA-compliant meta-analysis. Zhang Z; Xin S; Gao M; Cai Y Medicine (Baltimore); 2017 Apr; 96(17):e6708. PubMed ID: 28445279 [TBL] [Abstract][Full Text] [Related]
15. Association Between MGMT Promoter Methylation and Breast Cancer: a Meta-Analysis. An N; Shi Y; Ye P; Pan Z; Long X Cell Physiol Biochem; 2017; 42(6):2430-2440. PubMed ID: 28848211 [TBL] [Abstract][Full Text] [Related]
16. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status. Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569 [TBL] [Abstract][Full Text] [Related]
17. Association between MGMT Promoter Methylation and Risk of Breast and Gynecologic Cancers: A Systematic Review and Meta-Analysis. Chen R; Zheng Y; Zhuo L; Wang S Sci Rep; 2017 Oct; 7(1):12783. PubMed ID: 28986566 [TBL] [Abstract][Full Text] [Related]
18. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells. Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327 [TBL] [Abstract][Full Text] [Related]
19. Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure. Scesnaite A; Jarmalaite S; Mutanen P; Anttila S; Nyberg F; Benhamou S; Boffetta P; Husgafvel-Pursiainen K Mutagenesis; 2012 Jul; 27(4):423-9. PubMed ID: 22217548 [TBL] [Abstract][Full Text] [Related]
20. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast. Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]